Metabolic Research

Exenatide

FDA-approved product existsWeight & metabolic
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

What is Exenatide?

FDA-approved exenatide products exist for improving glycemic control in specified patients with type 2 diabetes. Immediate-release and extended-release formulations have different schedules and handling.

Dosing as published

Approved labelExenatide injection prescribing information for type 2 diabetes
PopulationAdults covered by the approved indication
DoseStart at 5 mcg twice daily; after one month the label permits an increase to 10 mcg twice daily based on clinical response.
RouteSubcutaneous injection in the thigh, abdomen, or upper arm
FrequencyTwice daily within 60 minutes before the morning and evening meals, at least 6 hours apart
DurationLong-term use within the approved indication
PreparationReady-to-use 250 mcg/mL solution in 5 mcg and 10 mcg-per-dose prefilled pens; no reconstitution.
Source: Dosage and Administration section 2.1; Dosage Forms and Strengths section 3

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved products exist; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11

Primary sources

  1. 6.5/10MOTS-cWorth tryingWeight & metabolicNot FDA approvedMOTS-c is a 16-amino-acid mitochondrial-derived peptide discovered in Lee 2015 that activates AMPK through the folate and purine pathway.
  2. 6.2/10IpamorelinWorth tryingRecoveryNot FDA approvedIpamorelin is a selective growth-hormone secretagogue with strong receptor selectivity but almost no human efficacy data: its only completed human efficacy trial…
  3. 6.1/10TirzepatideWorth tryingWeight & metabolicFDA-approved product existsTirzepatide is a once-weekly subcutaneous dual GIP plus GLP-1 receptor agonist with unusually large weight-loss and glycemic effects.
  4. 6.0/10Semaglutide (GLP-1 Agonist)Worth tryingWeight & metabolicFDA-approved product existsSemaglutide is a prescription GLP-1 receptor agonist that produced 14.9% mean weight loss in STEP-1 and cut 3-point MACE by 20% in SELECT, but the 6.0-6.5/10 score holds…

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.